Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.
Braal CL, Hussaarts KGAM, Seuren L, Oomen-de Hoop E, de Bruijn P, Buck SAJ, Bos MEMM, Thijs-Visser MF, Zuetenhorst HJM, Mathijssen-van Stein D, Vastbinder MB, van Leeuwen RWF, van Gelder T, Koolen SLW, Jager A, Mathijssen RHJ. Braal CL, et al. Among authors: van leeuwen rwf, van gelder t. Breast Cancer Res Treat. 2020 Nov;184(1):107-113. doi: 10.1007/s10549-020-05829-6. Epub 2020 Aug 16. Breast Cancer Res Treat. 2020. PMID: 32803636 Free PMC article. Clinical Trial.
Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment.
Heijns JB, van der Burg ME, van Gelder T, Fieren MW, de Bruijn P, van der Gaast A, Loos WJ. Heijns JB, et al. Among authors: van gelder t, van der gaast a, van der burg me. Cancer Chemother Pharmacol. 2008 Oct;62(5):841-7. doi: 10.1007/s00280-007-0671-9. Epub 2008 Jan 19. Cancer Chemother Pharmacol. 2008. PMID: 18204842 Free PMC article.
Renal function as a predictor of irinotecan-induced neutropenia.
de Jong FA, van der Bol JM, Mathijssen RH, van Gelder T, Wiemer EA, Sparreboom A, Verweij J. de Jong FA, et al. Among authors: van der bol jm, van gelder t. Clin Pharmacol Ther. 2008 Aug;84(2):254-62. doi: 10.1038/sj.clpt.6100513. Epub 2008 Feb 20. Clin Pharmacol Ther. 2008. PMID: 18288083
The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users.
Bijl MJ, van Schaik RH, Lammers LA, Hofman A, Vulto AG, van Gelder T, Stricker BH, Visser LE. Bijl MJ, et al. Among authors: van gelder t, van schaik rh. Breast Cancer Res Treat. 2009 Nov;118(1):125-30. doi: 10.1007/s10549-008-0272-2. Epub 2009 Feb 3. Breast Cancer Res Treat. 2009. PMID: 19189212
Effects of CYP induction by rifampicin on tamoxifen exposure.
Binkhorst L, van Gelder T, Loos WJ, de Jongh FE, Hamberg P, Moghaddam-Helmantel IM, de Jonge E, Jager A, Seynaeve C, van Schaik RH, Verweij J, Mathijssen RH. Binkhorst L, et al. Among authors: van gelder t, van schaik rh. Clin Pharmacol Ther. 2012 Jul;92(1):62-7. doi: 10.1038/clpt.2011.372. Epub 2012 May 23. Clin Pharmacol Ther. 2012. PMID: 22617226 Clinical Trial.
Individualization of tamoxifen treatment for breast carcinoma.
Binkhorst L, van Gelder T, Mathijssen RH. Binkhorst L, et al. Among authors: van gelder t. Clin Pharmacol Ther. 2012 Oct;92(4):431-3. doi: 10.1038/clpt.2012.94. Epub 2012 Aug 22. Clin Pharmacol Ther. 2012. PMID: 22910442 Review.
481 results